Feed RVTY
RV

Revvity

RVTY · NYSE

$143.31 -0.19% (-$0.28)
1M +16.74%
Market Cap $16.0B
P/E Ratio 67.46x
Div. Yield 0.19%
ROE 3.27%

Bulios Fair Price

$81.8

42.9% downside

Current Price

$143.31

Undervalued Fair Value Overvalued

According to Bulios Fair Price, RVTY is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Strong
8/9
Valuation
27 /100
Expensive
EV/EBITDA 23.92x
P/S 5.50x
P/B 2.22x
Growth
3 /100
Declining
Rev. growth 4.82%
FCF growth 5.07%
Book val. growth 0.60%
Profitability
77 /100
Strong
Net margin 8.16%
Op. margin 12.32%
FCF margin 19.21%
Quality
15 /100
Poor
ROE 3.27%
ROA 1.97%
Asset turnover 0.24x
Debt
63 /100
Moderate
Current ratio 1.80x
Int. coverage 3.77x
Net debt/EBITDA 3.02x
Stability
51 /100
Moderate
Rev. volatility 11.03%
EPS volatility 249.07%
Profitable years 2

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about RVTY
Online

About the company

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Prahlad R. Singh

Employees

11,000

Headquarters

Waltham

Upcoming events

23 OCT

Ex-Dividend

Ex-dividend date

31d
26 OCT

Earnings

Upcoming earnings report

34d
13 NOV

Dividend Payment

Payment date

52d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.